Australian Researchers Testing Medical Pot for Pancreatic Cancer Treatment

By
Maureen Meehan

Researchers from Curtin University’s School of Biomedical Sciences in Perth, Australia are testing medical marijuana as a possible breakthrough treatment for pancreatic cancer, one of the most lethal diseases on the planet.

The project is being undertaken in collaboration with Zelda Therapeutics, a Perth-based biopharmaceutical company, which will import the cannabis from Canada.

The research, according to news.com.au, will examine the usefulness of cannabis formulations as stand-alone treatments in combination with existing chemotherapy drugs.

Pancreatic cancer, the 11th most prevalent cancer diagnosed in Australia, is difficult to detect in the early stages and is extremely aggressive. Only six percent of sufferers survive for five years following diagnosis, according to Cancer.net.

“After years of slow progress in the field of pancreatic cancer treatment, we hope to finally open the path to new therapies for pancreatic cancer,” Curtin University’s Professor Marco Falasca said.

Zelda Therapeutics, according to their website, said the project will seek to replicate the success of its cannabinoid formulations on breast cancer.

In November, Zelda announced the results of an experimental trial, claiming its THC-rich medical cannabis formula was as effective in reducing breast cancer tumor growth in mice as the chemotherapy drug Lapatinib.

The results, which saw Zelda’s share price surge, still require clinical trial validation.

According to Zelda: “There is a growing body of evidence that whole plant cannabinoid extracts can impede cancer growth and potentially render the tumor more responsive to chemotherapeutic agents.”

Zelda’s executive chairman Harry Karellis hopes the pancreatic research will demonstrate anti-cancer activity.

“Professor Falasca [from Curtin University] has an established reputation in studying pancreatic cancer using cannabinoids in Italy, the United Kingdom and more recently, in Australia,” he told news.com.au.

Zelda has partnered with leading cancer researchers at Complutense University of Madrid, Spain and also has ties to AusCann, which has plans to cultivate and manufacture MMJ in Western Australia.

For these cancer trials, AusCann will source the research material from its Canadian partner Canopy Growth Corporation, the world’s biggest medical cannabis cultivator.

You can keep up with all of HIGH TIMES’ marijuana news right here.

Maureen Meehan

Maureen Meehan is a New York-based writer, who has worked as a foreign correspondent for many years.

By
Maureen Meehan
Tags: Australia

Recent Posts

Intentional Medicine

Sun Roots Farm puts nature in charge.

19 seconds ago

The Gift of Flavor

Chef Maverick creates feel-good sauces and snacks that cater to dietary restrictions.

1 day ago

Louisiana Legislative Committee Unanimously Passes Adult-Use Cannabis Framework Bill

If signed into law, the Louisiana bill would establish a regulatory framework for recreational cannabis,…

2 days ago

Study Reveals State Cannabis Legalization Lowers Immigrant Deportation

There's just a false sense of security related to the federal government to worry about.

2 days ago

Vegans Rejoice as Farmers Switch from Chickens to Hemp

A trend is emerging among poultry farmers who are converting operations to industrial hemp farms.

2 days ago

Weed Made Me Less Angry. Now It Sometimes Makes Me Mad.

I was once angry. But weed helped. Then, weed kinda made me angry again.

2 days ago